SIE

207.55

-2.65%↓

AIR.FR

163.68

-3.25%↓

ENR.DE

148.6

-1.39%↓

RHM

1,456

-3.48%↓

HO

239.3

-1.77%↓

SIE

207.55

-2.65%↓

AIR.FR

163.68

-3.25%↓

ENR.DE

148.6

-1.39%↓

RHM

1,456

-3.48%↓

HO

239.3

-1.77%↓

SIE

207.55

-2.65%↓

AIR.FR

163.68

-3.25%↓

ENR.DE

148.6

-1.39%↓

RHM

1,456

-3.48%↓

HO

239.3

-1.77%↓

SIE

207.55

-2.65%↓

AIR.FR

163.68

-3.25%↓

ENR.DE

148.6

-1.39%↓

RHM

1,456

-3.48%↓

HO

239.3

-1.77%↓

SIE

207.55

-2.65%↓

AIR.FR

163.68

-3.25%↓

ENR.DE

148.6

-1.39%↓

RHM

1,456

-3.48%↓

HO

239.3

-1.77%↓

Search

Wienerberger AG

Отворен

22.56 -0.35

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

21.96

Максимум

22.6

Ключови измерители

By Trading Economics

Приходи

-70M

-5M

Продажби

-121M

1B

P/E

Средно за сектора

15.197

61.065

EPS

-0.04

Дивидентна доходност

4.06

Марж на печалбата

-0.477

Служители

20,368

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+14.46% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

4.06%

2.23%

Следващи печалби

25.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-414M

2.5B

Предишно отваряне

22.91

Предишно затваряне

22.56

Wienerberger AG Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.03.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23.03.2026 г., 22:55 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23.03.2026 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23.03.2026 г., 23:59 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

23.03.2026 г., 23:59 ч. UTC

Пазарно говорене

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23.03.2026 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23.03.2026 г., 23:37 ч. UTC

Пазарно говорене

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23.03.2026 г., 22:42 ч. UTC

Пазарно говорене
Значими събития в новините

Global Equities Roundup: Market Talk

23.03.2026 г., 22:42 ч. UTC

Пазарно говорене
Значими събития в новините

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23.03.2026 г., 22:40 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23.03.2026 г., 22:23 ч. UTC

Пазарно говорене

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23.03.2026 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23.03.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23.03.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23.03.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23.03.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23.03.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23.03.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23.03.2026 г., 22:18 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23.03.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23.03.2026 г., 22:08 ч. UTC

Пазарно говорене

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23.03.2026 г., 21:42 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

23.03.2026 г., 21:42 ч. UTC

Пазарно говорене

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23.03.2026 г., 21:10 ч. UTC

Значими събития в новините

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене
Печалби
Значими събития в новините

Basic Materials Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Wienerberger AG Прогноза

Ценова цел

By TipRanks

14.46% нагоре

12-месечна прогноза

Среден 33.698 EUR  14.46%

Висок 37.582 EUR

Нисък 29.064 EUR

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Wienerberger AG през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

2

Купи

2

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Wienerberger AG

Wienerberger AG is an international building materials company. The Company is the parent company of a building materials group whose business activities are classified into six segments: Clay Building Materials Eastern Europe, Clay Building Materials Western Europe, Pipes & Pavers Eastern Europe, Pipes & Pavers Western Europe, North America and Holding & Others. The Clay Building Materials Europe division covers activities in the areas of clay blocks, facing bricks and roof tiles. The Pipes & Pavers Europe division's product portfolio covers system solutions for building installations, fresh water supply, irrigation, wastewater and rainwater management, drainage, energy supply and data transfer, as well as special products for industrial applications and pavers. The North America division covers activities in the areas of facing bricks, plastic pipes and concrete products. The Holding & Others division covers activities in the areas of clay blocks and others.
help-icon Live chat